{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:03Z","timestamp":1791357243314,"version":"4.3.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T00:00:00Z","timestamp":1506988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Forest Research Institute, Inc"},{"name":"Gedeon Richter Plc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jad.2017.09.040","type":"journal-article","created":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T13:15:26Z","timestamp":1506345326000},"page":"239-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Clinically relevant response and remission outcomes in cariprazine-treated patients with bipolar I disorder"],"prefix":"10.1016","volume":"226","author":[{"given":"Willie","family":"Earley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Durgam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaifeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Ruth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Laszlovszky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi N.","family":"Yatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2017.09.040_bib1","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4088\/JCP.v63n0910","article-title":"Subsyndromal depression is associated with functional impairment in patients with bipolar disorder","volume":"63","author":"Altshuler","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.040_bib2","unstructured":"American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Fourth edition, (Text Revision), 2000, American Psychiatric Association; Washington, DC."},{"key":"10.1016\/j.jad.2017.09.040_bib3","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"Suppl 3","key":"10.1016\/j.jad.2017.09.040_bib4","first-page":"31","article-title":"An evidence-based medicine strategy for achieving remission in bipolar disorder","volume":"69","author":"Beyer","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.040_bib5","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.jad.2017.09.040_bib6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4088\/JCP.14m09081","article-title":"Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study","volume":"76","author":"Calabrese","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.040_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1399-5618.2003.02237.x","article-title":"Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania","volume":"5","author":"Chengappa","year":"2003","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.09.040_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bdi.12238","article-title":"The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial","volume":"17","author":"Durgam","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.09.040_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1399-5618.2005.00207.x","article-title":"Functional impairment in the remission phase of bipolar disorder","volume":"7","author":"Fagiolini","year":"2005","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.09.040_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jad.2010.10.018","article-title":"Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis","volume":"133","author":"Fountoulakis","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.09.040_bib11","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","article-title":"Treatment of bipolar disorder","volume":"381","author":"Geddes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2017.09.040_bib12","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.4088\/JCP.v66n0809","article-title":"Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of risperidone monotherapy","volume":"66","author":"Gopal","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.040_bib13","series-title":"ECDEU Assessment Manual for Psychopharmacology","first-page":"217","article-title":"Clinical global impressions","author":"Guy","year":"1976"},{"key":"10.1016\/j.jad.2017.09.040_bib14","first-page":"489","article-title":"Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments","volume":"7","author":"Jann","year":"2014","journal-title":"Am. Health Drug Benefits"},{"key":"10.1016\/j.jad.2017.09.040_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1399-5618.2003.00091.x","article-title":"A prospective, longitudinal study of percentage of time spent ill in patients with bipolar I or bipolar II disorders","volume":"6","author":"Joffe","year":"2004","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.09.040_bib16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.040_bib17","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.4088\/JCP.10m06347yel","article-title":"Bipolar disorder: new perspectives in health care and prevention","volume":"71","author":"Leboyer","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.040_bib18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.040_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.163.2.217","article-title":"Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"163","author":"Perlis","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.040_bib20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4088\/JCP.v67n0401","article-title":"Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials","volume":"67","author":"Perlis","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.040_bib21","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.040_bib22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jad.2014.11.018","article-title":"Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, Phase III trial","volume":"174","author":"Sachs","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.09.040_bib23","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1017\/S1461145709991246","article-title":"Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis","volume":"13","author":"Tamayo","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2017.09.040_bib24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1192\/bjp.bp.105.020321","article-title":"Influence of sub-syndromal symptoms after remission from manic or mixed episodes","volume":"189","author":"Tohen","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.040_bib25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1185\/030079905X46340","article-title":"Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies","volume":"21","author":"Vieta","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2017.09.040_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.09.040_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.040_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.comppsych.2005.08.001","article-title":"Comparisons of perceived quality of life across clinical states in bipolar disorder: data from the first 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participants","volume":"47","author":"Zhang","year":"2006","journal-title":"Compr. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717304901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717304901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:17:44Z","timestamp":1759022264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032717304901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":28,"alternative-id":["S0165032717304901"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2017.09.040","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinically relevant response and remission outcomes in cariprazine-treated patients with bipolar I disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2017.09.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}